Search:
 
Home > AIM > Company Profiles > Abcam

Price

Market

Sector

Market Cap
475.00p (10.00p) 2.15% Up AIM Retailers £168.18m
Add to company folder | Print
Articles Financial Data Charts Profile
Related Companies

Commentary

Research-grade antibodies producer & marketer via its own online catalogue

Recent Articles

Directors’ Dealings by Kathleen Hall 06/10/2008
Abcam 09/07/2008
Directors’ Dealings 31/03/2008
Abcam 10/03/2008

Recent Announcements

Directors' Dealings
 21/11/2008
Share Incentive Plan
 07/11/2008
LTIP Awards
 07/11/2008
Block Listing
 06/11/2008
Result of AGM
 03/11/2008
AGM Statement
 03/11/2008
Block Listing
 30/10/2008
Block Listing
 22/10/2008
Shareholding
 26/09/2008
Directors' Dealings
 24/09/2008
More

Articles from the Sector

ASOS 18/11/2008
Green swoops on Moss Bros 12/11/2008
Dignity 10/11/2008
Dreaming of a gloomy Christmas 03/11/2008
Greggs 15/10/2008
Ted Baker 08/10/2008
Government’s ‘recovery’ debunked 06/10/2008
H&T Group 20/08/2008
Southern Bear plans £7.5m takeover 06/08/2008
H&T: high growth, highly defensive 05/08/2008
More

Financial History
Financial Year End 30/06/2005 30/06/2006 30/06/2007 30/06/2008
Currency GBP GBP GBP GBP
Turnover 12.14 19.36 24.52 36.69
Operating Profit 2.92 4.51 5.04 7.37
Pretax Profit 2.98 4.83 5.53 7.95
Earnings After Tax 2.28 3.42 4.06 5.89
Profit Available For Dividend 0.00 0.00 0.00 0.00
Ordinary Dividends -1.32 0.00 0.00 0.00
Retained Profit 2.28 3.42 0.00 0.00
Shareholders Funds 3.21 15.07 18.89 24.12
Net Current Assets 2.46 13.98 0.00 0.00
Adjusted Earnings Per Share Undiluted 0.00 0.00 11.74 16.88
Adj Earnings Per Share 0.00 0.00 11.43 16.56
Dividend Per Share 4.79 2.70 3.99 5.60

Company Details

Address 332 Cambridge Science Park, Milton Road, Cambridge, CB4 OFW
Telephone 01223 696 000
Fax 01223 696 001

Executives

Chairman David Cleevely (9.50% holding)
Chief Executive Jonathan Milner (20.10% holding)
Finance Director Jeffrey Iliffe (0.00% holding)
Managing Director David Warwick (2.40% holding)

Main Shareholders

N W Brown Nominees: 11.3%
Unicorn Asset Management: 6.8%
Artemis Investment Management: 6.3%
Morley Fund Management: 5.6%

Advisers

Nominated Adviser Numis
Nominated Broker Numis
Solicitors Eversheds
Auditors Deloitte
Registrar Capita Registrars

Commentary

Research-grade antibodies producer & marketer via its own online catalogue

Company Data
Code ABC
Sedol GB00B0LWCX
Shares In Issue 35.406 m
Indices
Entry on AIM 03/11/2005
Interim Results Mar
Final Results Sep
Year End Jun
Accounts Due Dec
Int div payment Apr
Fin div payment Nov
Int net div per share 4.56
Fin net div per share 1.04
Probable CGT relief Yes